CELLNOVO

cellnovo-logo

They believe that conventional diabetes care technology is stuck in the past, and that it has failed to put first the needs and wants of patients who have to live with the condition and the daily demands of its treatment. Those with diabetes should be put back in control, and they should live a life that is as unaffected as possible by the need to manage their condition. The experience of managing diabetes should be as positive as possible. Thoughtful and innovative design should make things easier to understand and simpler to use. With belief in these ideals, they tore up convention. When they started, they did so with a focus only on how modern technology and beautiful design would make life easier for someone managing diabetes.

#People #Financial #More

CELLNOVO

Social Links:

Industry:
Biotechnology Diabetes Health Care Medical Device

Founded:
2002-01-01

Address:
Wales, Cumbria, United Kingdom

Country:
United Kingdom

Total Employee:
51+

Status:
Closed

Contact:
44 20 3058 1250

Email Addresses:
[email protected]

Total Funding:
102.54 M USD

Technology used in webpage:
Domain Not Resolving



Current Advisors List

alexia-perouse_image

Alexia Perouse Board of Directors @ CellNovo
Board_member

raphaรซl-wisniewski_image

Raphaรซl Wisniewski BOD @ CellNovo
Board_member

philippe-peltier_image

Philippe Peltier BOD @ CellNovo
Board_member

raj-parekh_image

Raj Parekh BOD @ CellNovo
Board_member

john-littlechild_image

John Littlechild BOD @ CellNovo
Board_member

bart-bergstein_image

Bart Bergstein BOD @ CellNovo
Board_member
2011-01-01

Current Employees Featured

chris-townsend_image

Chris Townsend
Chris Townsend Chief Operating Officer @ CellNovo
Chief Operating Officer

eric-beard_image

Eric Beard
Eric Beard CEO & Chairman @ CellNovo
CEO & Chairman
2011-01-01

didier-moire_image

Didier Moire
Didier Moire VP of Global Sales & Marketing @ CellNovo
VP of Global Sales & Marketing
2018-05-01

Founder


joseph-cefai_image

Joseph Cefai

julian-shapley_image

Julian Shapley

Stock Details


Company's stock symbol is EPA:CLNV

Investors List

european-investment-bank_image

European Investment Bank

European Investment Bank investment in Post-IPO Debt - CellNovo

kreos-capital_image

Kreos Capital

Kreos Capital investment in Post-IPO Debt - CellNovo

nesta-investments_image

Nesta Ventures

Nesta Ventures investment in Series B - CellNovo

edmond-de-rothschild-investment-partners_image

Andera Partners

Andera Partners investment in Series B - CellNovo

healthcare-ventures_image

HealthCare Ventures

HealthCare Ventures investment in Series B - CellNovo

omnes-capital_image

Omnes Capital

Omnes Capital investment in Series B - CellNovo

advent-venture-partners_image

Advent Venture Partners

Advent Venture Partners investment in Series B - CellNovo

auriga-partners_image

Auriga Partners

Auriga Partners investment in Series B - CellNovo

forbion-capital-partners_image

Forbion Capital Partners

Forbion Capital Partners investment in Series B - CellNovo

nbgi-ventures_image

NBGI Ventures

NBGI Ventures investment in Series B - CellNovo

More informations about "CellNovo"

CellNovo Company Profile - Office Locations, Competitors ... - Craft

Apr 29, 2020 CellNovo. Stock Price. โ‚ฌ0.1. 2020-04-29. Market Capitalization. โ‚ฌ2.4 M. 2020-04-27. CellNovo Summary. Company Summary. Overview. Our innovative insulin patch pump โ€ฆSee details»

Cellnovo Company Profile 2024: Valuation, Funding

Cellnovo General Information Description. Cellnovo Group SA is engaged in the development of a system for diabetes management. The product portfolio includes cordless micro-pump, an integrated monitoring device and a cellular โ€ฆSee details»

Cellnovo - Products, Competitors, Financials, Employees, โ€ฆ

Cellnovo is a medical technology company focused on diabetes management. The company offers a mobile, connected diabetes management system that includes a micro-pump for โ€ฆSee details»

Cellnovo to cease producing its insulin pumps and technology

Mar 29, 2019 Cellnovo, a company that made innovative insulin pump and diabetes management systems, has announced it will cease production of its systems. The company, โ€ฆSee details»

CellNovo - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial โ€ฆSee details»

CellNovo - Contacts, Employees, Board Members, Advisors & Alumni

Organization. CellNovo . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Highlights. Employee Profiles 3. Number of Board Member and Advisor โ€ฆSee details»

Cellnovo Stops Manufacturing and Commercial โ€ฆ

Mar 28, 2019 Cellnovo is listed on Euronext, Compartment C ISIN: FR0012633360 โ€“ Ticker: CLNV Cellnovo - Disclaimer This press release contains certain forward-looking statements.See details»

Cellnovo expands its organisation - MarketScreener

Oct 9, 2015 Cellnovo Executive Chairman to transition to Non-Executive Chairman Sophie Baratte appointed CEO Company expands management team ... -October 09, 2015 at 01:31 โ€ฆSee details»

Cellnovo - VentureRadar

Cellnovo is a mobile medical device company. The Cellnovo mobile diabetes management system is a symphony of connected devices (pump, mobile handset and website) that โ€ฆSee details»

French Diabetes Company Cellnovo Goes into โ€ฆ

Mar 29, 2019 Paris-based Cellnovo has cut down on staff as well as stopped manufacturing and selling its diabetes management system as the company found itself unable to scale up. Until this week, Cellnovo was selling a โ€ฆSee details»

CellNovo CEO and Key Executive Team | Craft.co

CellNovo's CEO & Chairman is Eric Beard. Other executives include Sofia Loannidou, Bod; John Littlechild, Bod and 1 others. See the full leadership team at Craft.See details»

Cellnovo | Advent Life Sciences

The Cellnovo system is the worldโ€™s first mobile diabetes management system, including an insulin patch pump, activity monitor, cellular-enabled wireless touchscreen handset with integrated โ€ฆSee details»

Cellnovo Insulin Pump - Diabetesnet.com

The Cellnovo Diabetes Management System includes an insulin patch pump, continuous activity monitor, and a cellular-enabled wireless touchscreen handset with integrated blood glucose โ€ฆSee details»

Cellnovo Files For 510(K) Approval With The FDA For Its ... - BioSpace

Nov 16, 2016 PARIS--(BUSINESS WIRE)--Regulatory News: Cellnovo Group (Paris:CLNV) (โ€œCellnovoโ€ CLNV:EN Paris), a medical technology company marketing the first mobile, โ€ฆSee details»

Cellnovo gets โ‚ฌ17.5M to Build an Artificial Pancreas for Diabetics

Jul 7, 2017 Cellnovo is a French medtech company with an all-in-one system to manage diabetes in the market. The company has now announced a capital raise of โ‚ฌ17.5M to boost โ€ฆSee details»

The Cellnovo Insulin Delivery System - PMC

Cellnovo Intelligent Delivery System โ€“ unique Cellnovo technology which monitors insulin delivery accuracy and can correct for insulin delivery errors (within operating tolerances). If the delivery โ€ฆSee details»

The Cellnovo Insulin Delivery System - touchENDOCRINOLOGY

Dec 2, 2016 โ€ข Cellnovo Intelligent Delivery System โ€“ unique Cellnovo technology which monitors insulin delivery accuracy and can correct for insulin delivery errors (within operating โ€ฆSee details»

The Cellnovo System: It's more than an insulin pump - YouTube

Nov 7, 2016 The Cellnovo Diabetes Management System not only offers the freedom and convenience of a miniaturised inslin pump and sleek handset controller, it also allow...See details»

Clinovo โ€“ Accelerating Clinical Development through Innovative โ€ฆ

Before joining Clinovo in 2021, Jeff has held Senior Business Development positions with Chiltern, Covance, ICON and PRA. Jeff has spent the past 13 years building successful FSP โ€ฆSee details»

linkstock.net © 2022. All rights reserved